msos
msos · page 2
- Markets & Stocks
Cannabis Stocks Today — Wednesday 13 May 2026: Organigram Slides to $1.11 as Sector Posts Broad Losses
Cannabis stocks carry the losses from Tuesday’s session into Wednesday morning, with US markets yet to open and all prices reflecting the 12 May close.
- Markets & Stocks
Cannabis Stocks Today — Friday 8 May 2026: Mixed Session as WM Technology Gains 14%
BoC Cannabis Index closes +0.61% but breadth turns negative as 23 of 38 names fall; WM Technology surges 14% while REFI leads losers down 5%.
- US & Canada
‘Not Immediately Compliant’: What the CRS Says America’s Rescheduling Order Actually Delivers
Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this route have hung over the industry.
- Markets & Stocks
Cannabis Stocks Today — Thursday 7 May 2026: Curaleaf Leads +9.4% as Sector Rallies
BoC Cannabis Index +1.67% on broad strength; Curaleaf +9.4% leads a 27-stock advance, IIPR -4.3% the day’s worst.
- Markets & Stocks
Cannabis Stocks Today — Wednesday 6 May 2026: Innovative Industrial Properties Leads +14.03% as Sector Rallies
BoC Cannabis Index gains +1.26% as Innovative Industrial Properties surges +14.03%, lifting US MSOs and ETFs in a synchronised cannabis rally.
- Markets & Stocks
Cannabis Stocks Today — Thursday 30 April 2026: Ayr Wellness Leads +30.7% as Sector Rallies
Cannabis stocks closed broadly higher Thursday with the BoC Cannabis Index up 2.65%, every ETF gaining at least 3.9%, and Ayr Wellness pacing the universe at +30.7% even as several US MSOs lagged the rally.
- Markets & Stocks
Cannabis Stocks Today — Wednesday 29 April 2026: Sector Slides as MAPS Falls 12.9%
The BoC Cannabis Index fell roughly 3.3% on Wednesday with 32 of 39 tracked stocks closing lower; Trulieve led gainers (+7.0%) while WM Technology slumped 12.9%.
- Markets & Stocks
Cannabis Stocks Today — Tuesday 28 April 2026: Cresco Labs Leads +19% as US MSOs Rally
BoC Cannabis Index edges +0.34% as US multi-state operators rally led by Cresco Labs +19%, while cannabis ETFs and Canadian LPs slide.
- Policy & Regulation
The US Officially Reschedules Cannabis, Partly….
After years of false starts, political delays and administrative paralysis, the United States federal government has taken its first concrete step toward rescheduling cannabis.
- Investment & Finance
Federal Agencies Reportedly Told to Prep for Imminent Cannabis Rescheduling Announcement
Cannabis stocks have once again been sent flying in the wake of the latest hint of progress on cannabis rescheduling from Trump’s White House.
- CBD Market
CBD Enters US Healthcare Through Medicare Pilot, But Coverage Remains Limited
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost cannabis stocks.
- Industry Trends
Rescheduling Stalemate Leaves MSOs Facing a Billion Dollar Tax Reckoning
The Trump administration’s continued inaction on its promise to push ahead with the highly anticipated cannabis rescheduling project is now presenting some real-world issues for many of the sector’s largest players.
